Seres Therapeutics, Inc. (MCRB)
Market Closed
16 Oct, 08:00 PM
$
2. 51
-0.02
-0.7905%
$
26.24M Market Cap
- P/E Ratio
- Div Yield
2,972 Volume
-0.99 Eps
$ 2.53
Previous Close 
Want to track MCRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seres Therapeutics, Inc. (MCRB) Statistics
Valuation metrics
Market Cap 26.24M
Enterprise value 67.29M
Trailing P/E (ttm) -1.14
Forward P/E -0.93
PEG ratio 0
Price/Sales (ttm) 13.94
Price/Book (mrq) 0.76
Enterprise Value/Revenue 35.74
Enterprise Value/EBITDA -1.5
Overview
Shares outstanding 9.56M
Float 7.28M
Shares short 597.31K
% Held by insiders 0.12%
% Held by institutions 0.26%
Average volume (10 days) 79.4K
Average volume (90 days) 53.97K
Price summary
52-Week low 2.38
52-Week high 29.98
Beta 0.26
50-Day moving average 3.25
200-Day moving average 7.84
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 22 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -11.93%
Operating margin -44.63%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.6%
Income Statement
Revenue (ttm) 789K
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -54.81M
EBITDA -89.84M
Net income to common (ttm) 5.7M
Diluted EPS (ttm) -2.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 45.77M
Total cash per share (mrq) 1.62
Total debt (mrq) 82.97M
Total Debt/Equity (mrq) 1.64
Current ratio (mrq) 2.11%
Book value per share (mrq) 3.58
Cash Flow
Cash flow statement 1.12M
Levered free cash flow (LFCF) -54.96M
2026 © Marketlog. All Rights Reserved.
